Ultrafen Extra IM Injection 75 mg + 20 mg / 2 ml

Ultrafen Extra IM Injection, manufactured by Beximco Pharmaceuticals Ltd, combines Diclofenac Sodium (75 mg) and Lidocaine Hydrochloride (20 mg) in a 2 ml IM Injection. Priced at ৳15.00 per unit, it addresses moderate-to-severe pain and inflammation in conditions like arthritis, musculoskeletal disorders, and post-surgical pain. The addition of Lidocaine minimizes injection site discomfort, enhancing patient compliance.

This NSAID inhibits prostaglandin synthesis, offering analgesic, anti-inflammatory, and antipyretic effects. Lidocaine blocks nerve signals locally, ensuring rapid pain relief. Adults typically receive one ampoule daily via intramuscular injection, with dosage adjustments for renal colic or severe cases. Elderly patients require careful monitoring to avoid adverse effects.

Key indications include rheumatoid arthritis, osteoarthritis, gout, tendonitis, and post-traumatic pain. Patients should avoid combining it with lithium, anticoagulants, or other NSAIDs due to potential interactions. Common side effects include gastrointestinal discomfort, while severe reactions like bleeding or CNS effects are rare.

Stored below 30°C and protected from light, Ultrafen Extra IM Injection is contraindicated in late pregnancy. Breastfeeding mothers should consult doctors. For optimal use, follow prescribed guidelines and monitor for side effects of Ultrafen Extra IM Injection to ensure safe treatment outcomes.

Adults: 1 ampoule once daily via intramuscular injection (twice in severe cases). For renal colic, a second dose may be given after 30 minutes. Children: 1-3 mg/kg Diclofenac Sodium for juvenile arthritis. Elderly patients should receive the lowest effective dose. The IM injection containing Lidocaine reduces injection-site pain.

Side effects to Diclofenac Sodium and Lidocaine injection are usually mild and transient. However if serious side effects occur the injection should be discontinued. Gastrointestinal discomfort, nausea, diarrhea and occasionally bleeding may occur. In very rare instances, injection site disorder may occur. In isolated cases, abscesses and local necrosis may occur. The adverse effects due to Lidocaine mainly involve the CNS, are usually of short duration, and are dose related. The CNS reactions may be manifested by drowsiness, dizziness, disorientation, confusion, lightheadedness etc.

Avoid during pregnancy (especially third trimester) unless absolutely necessary. Small amounts of Diclofenac in breast milk are unlikely to harm infants.

Monitor hepatic/renal/cardiac function in high-risk patients. Regular blood tests required for long-term use. Follow Beximco Pharmaceuticals’ guidelines.

Children: Weight-based dosing for juvenile arthritis. Elderly: Start with lowest dose. Renal/Hepatic impairment: Dose adjustment required.